Joinn Laboratories (China) Co Ltd 2021 SR
The report highlights JOINN's commitment to non-clinical drug safety assessment and its expansion into comprehensive CRO services. In 2021, the company expanded its environmental data statistical scope to include both Beijing and Suzhou facilities. Key achievements include maintaining zero work-related fatalities for three consecutive years and implementing a fourth phase of its A-share restricted share incentive scheme. The company also focused on R&D quality management, supply chain integrity, and community engagement, including a significant donation to the Zhongguancun Kexin Children's Drug Innovation Institute.
Company: Joinn Laboratories (China) Co Ltd
Sector: Professional & technical services
Country: China
Year: 2021
Type: SR
Pages: 38
Back to company
Joinn Laboratories (China) Co Ltd
ESG Report
The report highlights JOINN's commitment to non-clinical drug safety assessment and its expansion into comprehensive CRO services. In 2021, the company expanded its environmental data statistical scope to include both Beijing and Suzhou facilities. Key achievements include maintaining zero work-related fatalities for three consecutive years and implementing a fourth phase of its A-share restricted share incentive scheme. The company also focused on R&D quality management, supply chain integrity, and community engagement, including a significant donation to the Zhongguancun Kexin Children's Drug Innovation Institute.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jan 1, 2021 - Dec 31, 2021
Fiscal Year
2021
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Water Consumption
Total Waste
Workplace Fatalities
Employees